Report: Cardiac risks must be considered when treating COVID-19

Report: Cardiac risks must be considered when treating COVID-19

Publication date: Sep 19, 2025

“This statement [report] provides unified, practical recommendations for prevention, rehabilitation, and long-term care, while also identifying critical research gaps to ensure strategies continue to evolve with emerging evidence. The authors said the number of cardiac rehabilitation centers in Europe are too few given the increasing burden of long COVID. “Patients hospitalized with COVID-19 exhibit an elevated risk of cardiovascular events lasting up to 3 years post-infection,” the authors wrote. “Comprehensive prevention strategies should incorporate pharmacological and lifestyle interventions to address residual cardiovascular risks. “More long-COVID clinics neededThe authors also addressed long COVID. “Health systems must be prepared for the ongoing burden, not just the acute infection. “

Concepts Keywords
Cardiology Cardiac
Europe Cardiovascular
Infectionshould Covid
Muscle Disease
Phd European
Heart
Infection
Journal
Long
Prevention
Rehabilitation
Report
Risk
Risks
Vaccination

Semantics

Type Source Name
disease IDO acute infection
disease MESH COVID-19
disease MESH cardiovascular risk
pathway REACTOME SARS-CoV-2 Infection
disease MESH infection
disease MESH long COVID
disease MESH complications
disease MESH cardiovascular disease
disease MESH myocarditis
disease MESH inflammation
disease MESH myocardial infarction
disease MESH heart failure
disease MESH thromboembolism
disease MESH blood clot
disease MESH uncertainty
pathway REACTOME Release
disease MESH heart disease
disease MESH lifestyle
disease MESH chest pain
disease MESH breathlessness
disease MESH arrhythmia

Original Article

(Visited 5 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *